Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Byrd

Showing results (471-480 of 1,058) with videos related to

Pageof 106
Sort By:
Human Vaccines & Immunotherapeutics|May 4, 2026
Population-level prevalence and risk of oral HPV infection with or without HPV vaccinationMorgan C Byrd, Alexandra E Hunter, Osayamen Atekha, et al.
Analytical Biochemistry|March 1, 1988
Structural characterization of intact, branched oligosaccharides by high performance liquid chromatography and liquid secondary ion mass spectrometryJ W Webb, K Jiang, B L Gillece-Castro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2005
Phase I study of low-dose interleukin-2, fludarabine, and cyclophosphamide for previously untreated indolent lymphoma and chronic lymphocytic leukemiaYvette L Kasamon, Ian W Flinn, Michael R Grever, et al.
Glycobiology|December 1, 1994
Alterations of O-glycan biosynthesis in human colon cancer tissuesJ M Yang, J C Byrd, B B Siddiki, et al.
Cancer|September 20, 2013
Phase 2 trial of rituximab and bortezomib in patients with relapsed or refractory mantle cell and follicular lymphomaRobert A Baiocchi, Lapo Alinari, Mark E Lustberg, et al.
Haematologica|November 2, 2014
Reduced dose pentostatin for initial management of hairy cell leukemia patients who have active infection or risk of hemorrhage is safe and effectiveLeslie A Andritsos, Neil Dunavin, Gerard Lozanski, et al.
Dermatology Online Journal|April 18, 2021
Clinical interventions aimed at expanding access to dermatologic careAndrew S Desrosiers, Curtis J Petruzzelli, John Fg Bobo, et al.
Leukemia|December 13, 2005
Alemtuzumab induces caspase-independent cell death in human chronic lymphocytic leukemia cells through a lipid raft-dependent mechanismA P Mone, C Cheney, A L Banks, et al.
Veterinary and Comparative Oncology|May 3, 2016
Non-immunosuppressive FTY720-derivative OSU-2S mediates reactive oxygen species-mediated cytotoxicity in canine B-cell lymphomaR Mani, R Yan, X Mo, et al.
Cureus|October 20, 2023
The Effectiveness of a Mobile Health Clinic Delivering Mandatory and Elective Middle School Immunizations: A Descriptive AnalysisNatalie R LaGattuta, Taylor C Wilson, Jordan A Failla, et al.
Pageof 106

Showing results (471-480 of 1,058) with videos related to

Sort By:
Pageof 106
Human Vaccines & Immunotherapeutics|May 4, 2026
Population-level prevalence and risk of oral HPV infection with or without HPV vaccinationMorgan C Byrd, Alexandra E Hunter, Osayamen Atekha, et al.
Analytical Biochemistry|March 1, 1988
Structural characterization of intact, branched oligosaccharides by high performance liquid chromatography and liquid secondary ion mass spectrometryJ W Webb, K Jiang, B L Gillece-Castro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2005
Phase I study of low-dose interleukin-2, fludarabine, and cyclophosphamide for previously untreated indolent lymphoma and chronic lymphocytic leukemiaYvette L Kasamon, Ian W Flinn, Michael R Grever, et al.
Glycobiology|December 1, 1994
Alterations of O-glycan biosynthesis in human colon cancer tissuesJ M Yang, J C Byrd, B B Siddiki, et al.
Cancer|September 20, 2013
Phase 2 trial of rituximab and bortezomib in patients with relapsed or refractory mantle cell and follicular lymphomaRobert A Baiocchi, Lapo Alinari, Mark E Lustberg, et al.
Haematologica|November 2, 2014
Reduced dose pentostatin for initial management of hairy cell leukemia patients who have active infection or risk of hemorrhage is safe and effectiveLeslie A Andritsos, Neil Dunavin, Gerard Lozanski, et al.
Dermatology Online Journal|April 18, 2021
Clinical interventions aimed at expanding access to dermatologic careAndrew S Desrosiers, Curtis J Petruzzelli, John Fg Bobo, et al.
Leukemia|December 13, 2005
Alemtuzumab induces caspase-independent cell death in human chronic lymphocytic leukemia cells through a lipid raft-dependent mechanismA P Mone, C Cheney, A L Banks, et al.
Veterinary and Comparative Oncology|May 3, 2016
Non-immunosuppressive FTY720-derivative OSU-2S mediates reactive oxygen species-mediated cytotoxicity in canine B-cell lymphomaR Mani, R Yan, X Mo, et al.
Cureus|October 20, 2023
The Effectiveness of a Mobile Health Clinic Delivering Mandatory and Elective Middle School Immunizations: A Descriptive AnalysisNatalie R LaGattuta, Taylor C Wilson, Jordan A Failla, et al.
Pageof 106